Clinical Research Directory
Browse clinical research sites, groups, and studies.
Cyclosporine Vs Steroids in DRESS
Sponsor: University of Southern California
Summary
Current treatments for patients with drug reaction with eosinophilia and systemic symptoms (DRESS) include supportive care, steroids and cyclosporine. No randomized controlled trial (RCT) exists in comparing these treatments and all available literature comes in the form of case reports and case series. These two treatments are considered standard of care and this trial seeks only to compare outcomes of DRESS between these two therapies. No additional labs, therapies or procedures will be used apart from those that are routinely done for patients with this diagnosis. This will be a pilot study to determine efficacy of the two therapies with particular endpoints in mind so that the investigators can study the safety of these two therapies in patients with DRESS. Data suggests a potential benefit for adults with DRESS using either steroids or cyclosporine but the investigators are seeking a comparison of efficacy of these two therapies. The study population will include adults with a Registry of Severe Cutaneous Adverse Reaction (RegiSCAR) score of greater than 4 (i.e. a likely diagnosis of DRESS). The investigators will exclude patients with sepsis, active Hepatitis B or C, active tuberculosis, a documented allergy to steroids or cyclosporine, and patients with an estimated glomerular filtration rate (eGFR) \< 30 (unless on dialysis in which case the participants will be included).
Official title: A Randomized Controlled Pilot Trial of Cyclosporine Vs Steroids in DRESS
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
50
Start Date
2021-09-27
Completion Date
2026-06-30
Last Updated
2025-03-30
Healthy Volunteers
No
Interventions
Cyclosporine
Patients randomized to cyclosporine will be treated as mentioned under "Arm/Group Description"
Methylprednisolone and Prednisone
All patients randomized to steroids will initially be treated with IV methylprednisolone and eventually started on an oral prednisone taper.
Locations (1)
USC
Los Angeles, California, United States